Trial · NCT01751724
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Age at First Successful Extubation | From birth to until 36 weeks postmenstrual age | Defined as age of extubation with infant remaining extubated for more than 24 hours. |
| Secondary | Survival | From the time of randomization up to 36 weeks corrected age, or until the time of discharge or death | |
| Secondary | Total Duration of Mechanical Ventilation | From the time of first intubation until the last extubation, up to 36 weeks corrected age | |
| Secondary | Total Duration of Oxygen Supplementation | From the time of first initiation until the last day of oxygen supplementation, up to 36 weeks corrected age | |
| Secondary | Number of Infants With Bronchopulmonary Dysplasia (BPD) | Evaluated at 36 weeks corrected postmenstrual age | BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age. |
| Secondary | Survival Without BPD | From the time of randomization until 36 weeks corrected age, discharge or death | Discharge alive without BPD. BPD defined as need for oxygen for at least 28 days and at 36 weeks post-menstrual age. |
| Other | Number of Infants With Pulmonary Hemorrhage | From enrollment until 36 weeks postmenstrual age, discharge or death | |
| Other | Number of Infants With Necrotizing Enterocolitis | From enrollment until 36 weeks postmenstrual age, discharge or death | |
| Other | Number of Infants With Septicemia | From enrollment until 36 weeks postmenstrual age, discharge or death | Septicemia defined as positive blood culture |
| Other | Number of Infants With Severe Intraventricular Hemorrhage | From enrollment until 36 weeks postmenstrual age, discharge or death | Severe intraventricular hemorrhage defined as grade III or higher |
| Other | Number of Infants With Severe Retinopathy of Prematurity | From enrollment until 36 weeks postmenstrual age, discharge or death | Severe retinopathy of prematurity defined as stage 3 or higher |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01751724/registered